The treat-to-target (T2T) concept has improved outcomes for patients with diabetes,
hypertension and rheumatoid arthritis. This therapeutic strategy involves choosing a well …

The pharmacological treatment of systemic lupus erythematosus (SLE) aims to decrease
disease activity, progression, systemic compromise, and mortality. Among the …

Systemic lupus erythematosus (SLE) is a complex autoimmune disease with a poorly
understood preclinical stage of immune dysregulation and symptom accrual. Accumulation …

Systemic lupus erythematosus (SLE) is an autoimmune disease often used as a model in
genomics research. The downregulation of microRNA‑101‑3p (miR‑101‑3p) participates in …

Background: Dyslipidemia is a common disorder in systemic lupus erythematosus (SLE)
patients. It is still inconclusive whether antimalarial drugs could affect the serum lipids in SLE …

Introduction Systemic lupus erythematosus is an autoimmune disease associated with
serious complications and high costs. The aim was to describe the clinical characteristics …

The cytoplasmic tail of CD45 (ct‐CD45) is proteolytically cleaved and released upon
activation of human phagocytes. It acts on T cells as an inhibitory, cytokine‐like factor in …

Regarding applicative, facile, green chemical research, a bio-inspired approach is being
reported for the synthesis of Au nanoparticles by pectin (PEC) as a natural reducing and …

Progressive multifocal leukoencephalopathy (PML) caused by reactivation of the JC virus
(JCV), a human polyomavirus, occurs in autoimmune disorders, most frequently in systemic …

In rheumatology practice, the risk of hepatotoxicity from medications, including non-steroidal
anti-inflammatory drugs, notably, and methotrexate, sulfasalazine, leflunomide, and …